Why Two Sources Disagree About the Same Compound

Different websites say different things about the same peptide because they are usually describing different evidence. One page read the animal studies and reported what those found. Another looked for studies in people, found almost none, and reported that. Both writers wrote down what they saw, and the two summaries point opposite ways without anybody lying.

Here is how it goes from your side. You hear a name somewhere and look it up. The first page calls the compound promising and mentions research. The second says there is no real evidence, and also mentions research. You close the tabs knowing less than when you opened them.

That is genuinely confusing, and the confusion is not a failure on your part. You checked more than one source, which is the advice everybody gives, and the advice never says what to do when the sources disagree. So that is what this page is for. Not how to work out who is lying, because usually nobody is, but the ordinary reasons two honest pages leave opposite impressions. A companion piece here takes apart a single claim, sentence by sentence. This one is about what to do when two claims collide.

Are they even describing the same studies?

Start with the commonest reason, which is also the easiest to miss. Picture a compound with thirty published studies attached to its name. Twenty-eight were done in mice, or in cells grown in a dish. Two were small studies in people, and nobody has repeated either. One writer reads the twenty-eight and describes a compound with a substantial body of research behind it, which is a true sentence.

A second writer asks a narrower question: how many solid trials in humans exist? The answer is close to none, so that page reports the evidence in people is thin. That is also true, written from the same shelf of studies.

Now set the two pages beside each other. One reads as encouraging and one reads as dismissive. Neither writer hid anything on purpose; they stood in different places and described the view. And the gap between those views is real: reviewers who line animal results up against the human trials that came later keep finding the two agree only patchily 2.

Are they answering the same question?

This one is close to the first, and worth separating out. "Does this compound do something in the body?" and "does this compound help a person?" are two questions with different answers. Articles very often do not say which one they took on.

A compound can be genuinely active, attaching to a receptor, changing what a cell produces, moving a measurement in a laboratory. That is real, and it answers the first question with a firm yes. Whether a person feels better is a separate question. The compound still has to survive the body, arrive where it is needed in a useful amount, and do enough there to be noticed.

So one page can say it works and another can say it does not, with both correct. The first finished the sentence with "in cells." The second finished it with "in patients." Neither ending was said out loud, which left you holding two halves that do not fit.

Is one of them simply older?

Evidence has dates on it, and web pages usually do not. Imagine a page written in a year when a compound had encouraging early work and no human trials, describing that situation accurately at the time. Two years later a trial reports, the honest answer changes, and the page does not change with it.

This runs both directions, since a cautious page can go stale too. It may still say nothing has been tested in people, because it was written before the testing happened. Almost nobody updates old writing, which is unpaid work that brings no new readers. So when two sources clash, look for a date near the title, or for the newest study each page names.

Why does the published record lean positive before anyone writes about it?

This is the least known reason on the list, and probably the most important. It happens well before any writer sits down. Publication bias means that studies which find something are more likely to be published than studies which find nothing. A team tests a compound, sees an effect, and writes it up. Journals want that paper, so it appears and gets read and cited. Another team tests the same compound and sees nothing. That is a duller paper, journals are less interested, and the work often stays in a drawer.

Nobody in that story is behaving badly. But add it up across a field and the record tilts, because the studies you can find are not a fair sample of the studies that were run. The ones that found something survived to be findable. So a writer who honestly summarizes everything published is already summarizing a filtered set 1.

It is also part of why animal work so often looks stronger than the human trials that follow it 2. And it means the encouraging page may have done nothing wrong: it read the literature faithfully, and the literature was already leaning.

Do they count the same things as evidence?

Two writers can read exactly the same studies and still disagree, because they use different bars for what counts. One counts any published finding: if the work was done properly and appeared in a journal it goes on the pile. By that standard, a compound with thirty animal papers behind it has real evidence.

Another counts only randomized trials in people, meaning studies where volunteers are assigned by chance to receive the treatment or not, which is the fairest test anyone has devised. By that standard the same compound has close to nothing, and saying so is just as fair.

Neither writer is being dishonest; they are using the word evidence to mean two different things. That disagreement will never resolve, because it was never about the compound at all. Both answers stand, and you can stop waiting for the argument to be settled.

Does somebody have an interest?

This deserves saying plainly, and it deserves saying evenly. A page that sells something has a reason to lead with the promising half of the evidence. That is not the same as a reason to lie, since the promising half genuinely exists and is there to be reported. It simply gets the headline, while the disappointing half gets a shorter mention further down.

The same pressure works in the other direction, and it is less often admitted. A writer known for debunking has an audience that arrived for debunking. A piece concluding "this looks reasonably promising, actually" does not land well with them. So the cautious half gets the emphasis instead.

Neither of these makes anybody a liar, because interest shapes emphasis far more often than it produces false statements. So "who wrote this?" tells you which half to expect more of, not whether that half is accurate. Treat it as a nudge, and go looking for the part you can guess was compressed.

So what do you do when two sources disagree?

Here is the practical part, and the reason this page exists. The instinct is to work out which source is more trustworthy. Rank them, pick a winner, believe that one. It feels responsible, but it does not work, because both pages look equally reasonable. So try a different move: do not ask who is right, ask what each one is actually describing.

1. What did each page read? If one is built on animal work and the other on trials in people, you already have your answer.
2. What question is each one answering — does the compound do something, or does it help a person? The examples usually give it away.
3. When was each one written? Look for a date, or for the newest study each page names.
4. What counts as evidence to each writer? "Studies suggest" and "no controlled trials in humans" are two standards, not two opinions about one standard.
5. What would each page say about the other's evidence? Often the encouraging page would agree there are no human trials, and just did not think that was the headline.

Nine times out of ten, one of those questions dissolves the disagreement. You find that the pages were describing different piles of evidence, and once you can see both piles there is nothing left to settle. What you hold is more accurate than either page alone. Something interesting happened in animals, and nobody has yet shown it happens in people.

One study is not a finding

One more piece, and it is honest rather than comfortable. Even when two sources agree, agreement is not certainty. A single study reports something that happened once, in one place, to one group. Any experiment can come out oddly by chance, or because of something particular to that laboratory. The check on this is replication, which means another team running the same experiment independently to see whether the same thing happens.

It matters more than most people expect. When one group set out to reproduce 53 well-known preclinical studies — preclinical meaning work done before any human testing — they confirmed 6 of them 3. A later analysis estimated that more than half of preclinical research cannot be reproduced 4.

So a fair working definition is this: a finding is something more than one group has seen. Below that line a study is a suggestion, and suggestions are how everything worthwhile begins. But two pages arguing over a single unrepeated study are arguing about something thinner than either realizes.

Where this leaves you

Disagreement between two sources is usually not a sign that one of them is lying to you. It is a sign that the evidence is incomplete, and incompleteness is the normal condition of most questions worth asking. Settled questions do not produce two pages that clash; they produce one dull paragraph everybody repeats.

That reframing does more than it sounds like. Instead of an argument you have to win, you have a picture that is partly filled in, and you can hold both descriptions at once. "Promising in animals, untested in people" is not a contradiction. It is one accurate sentence that took two pages to arrive at.

So the next time two tabs contradict each other, you will not have to decide who to believe. You can just look for what each one read. That is usually sitting in the first few paragraphs, and once you find it the disagreement quietly turns into information.